ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 95 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2019. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $29 | +123.1% | 18 | 0.0% | 0.00% | – |
| Q1 2023 | $13 | +30.0% | 18 | 0.0% | 0.00% | – |
| Q4 2022 | $10 | – | 18 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 18 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 18 | -100.0% | 0.00% | – |
| Q1 2022 | $62,000 | -33.3% | 47,178 | -10.6% | 0.00% | – |
| Q4 2021 | $93,000 | -13.9% | 52,776 | +5.6% | 0.00% | – |
| Q3 2021 | $108,000 | -94.2% | 49,988 | -90.6% | 0.00% | -100.0% |
| Q2 2021 | $1,866,000 | +161.7% | 532,930 | +636.0% | 0.00% | – |
| Q1 2021 | $713,000 | -26.3% | 72,413 | -18.8% | 0.00% | -100.0% |
| Q4 2020 | $967,000 | -91.0% | 89,223 | -91.4% | 0.00% | -85.7% |
| Q3 2020 | $10,721,000 | +1087.3% | 1,040,815 | +2306.3% | 0.01% | +600.0% |
| Q2 2020 | $903,000 | -11.9% | 43,253 | -58.7% | 0.00% | 0.0% |
| Q1 2020 | $1,025,000 | -59.5% | 104,817 | -52.3% | 0.00% | -50.0% |
| Q4 2019 | $2,530,000 | +441.8% | 219,774 | +155.7% | 0.00% | – |
| Q3 2019 | $467,000 | +17.6% | 85,966 | +156.6% | 0.00% | – |
| Q2 2019 | $397,000 | +14.4% | 33,508 | -49.8% | 0.00% | – |
| Q1 2019 | $347,000 | -8.4% | 66,689 | -44.7% | 0.00% | – |
| Q4 2018 | $379,000 | -83.4% | 120,493 | -68.0% | 0.00% | -100.0% |
| Q3 2018 | $2,277,000 | -32.7% | 376,730 | -41.0% | 0.00% | 0.0% |
| Q2 2018 | $3,383,000 | +126.3% | 638,630 | +147.6% | 0.00% | 0.0% |
| Q1 2018 | $1,495,000 | +11.5% | 257,938 | -32.7% | 0.00% | 0.0% |
| Q4 2017 | $1,341,000 | +97.2% | 383,330 | +105.6% | 0.00% | – |
| Q3 2017 | $680,000 | +176.4% | 186,445 | +88.6% | 0.00% | – |
| Q2 2017 | $246,000 | -27.9% | 98,839 | -22.4% | 0.00% | – |
| Q1 2017 | $341,000 | +11.1% | 127,343 | +19.5% | 0.00% | – |
| Q4 2016 | $307,000 | -71.2% | 106,523 | -59.0% | 0.00% | -100.0% |
| Q3 2016 | $1,065,000 | +32.1% | 259,539 | +1.7% | 0.00% | 0.0% |
| Q2 2016 | $806,000 | – | 255,214 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 4,112,355 | $40,178,000 | 34.81% |
| Versant Venture Management, LLC | 7,068,233 | $69,056,636,000 | 18.94% |
| ACUTA CAPITAL PARTNERS, LLC | 1,704,500 | $16,653,000 | 8.07% |
| Soleus Capital Management, L.P. | 313,900 | $3,067,000 | 3.57% |
| Ghost Tree Capital, LLC | 1,305,500 | $12,755,000 | 3.38% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $4,690,000 | 2.97% |
| RTW INVESTMENTS, LP | 6,631,627 | $64,791,000 | 2.79% |
| VR Adviser, LLC | 994,381 | $9,715,000 | 2.63% |
| Avoro Capital Advisors LLC | 7,150,000 | $69,856,000 | 2.36% |
| RA Capital Management | 7,272,714 | $71,054,000 | 2.24% |